# IPTi in Mozambican Infants for Malaria Prevention

> **NCT00209794** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hospital Clinic of Barcelona** · enrollment: 1498 (—)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Sulfadoxine-Pyrimethamine (Fansidar)

## Key facts

- **NCT ID:** NCT00209794
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 1498 (—)
- **Last updated:** 2006-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209794, "IPTi in Mozambican Infants for Malaria Prevention". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00209794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*